Jeff Liter brings to PCT a breadth of multi-function expertise including operations, finance, merger & acquisition integration, corporate development, strategy development and sales. Additionally, his work experiences spans multiple industries with his most recent four years being dedicated to the life sciences. In his consulting role for On Point (a privately-held company), Jeff led complex international integration initiatives for the likes of Beckman Coulter, Onyx Pharmaceuticals, and Haemonetics. Jeff worked for On Point in 2009 and again in 2012. Additionally, from January 2010 to late in 2011 Jeff spent nearly two years working as the Director of Strategy, Licensing, & Corporate Development for Beckman’s Diagnostic Division which was acquired by Danaher Corporation in late 2011. Prior to 2009 Jeff spent nearly ten years working for ADC Corporation where from 2007 to 2008 Jeff led ADC’s Corporate Development Team.
Jeff has conducted well over a dozen M&A transaction across the globe ranging from $4 million to $2.6 billion. His integration efforts have included consolidating multi-national manufacturing plants and ensuring the appropriate registrations and line validations across varying regulatory bodies were effectively incorporated into the transition plans. Jeff has led operational restructuring in the United States, several countries in Europe, Australia, and China. He brings a vast set of experiences in working with government agencies, regulating bodies, and works councils in streamlining operations through time urgent transitions. Jeff has a MBA in Finance from the University of Minnesota.